Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Facebook Roundtable: COVID-19 vs Cancer - The future of cancer research

ESMO Facebook Roundtable: 'COVID-19 vs Cancer: The Future of Cancer Research'

The effects of pandemic-related contingency measures on current cancer research and future advances

During the early stages of the COVID-19 pandemic, many clinical trials and research activities in oncology have been temporarily suspended or delayed. What are the implications of contingency measures on cancer research?

In the second ESMO Facebook Round Table on COVID-19 vs Cancer, leading cancer experts share their perspectives on the state-of-art of cancer research after the first wave of coronavirus infections and reflect on current issues including the need of resource reallocation and lack of funding.

In the panel

  • Solange Peters, Switzerland
  • Fabrice André, France
  • Alessandra Curioni-Fontecedro, Switzerland
  • Rodrigo Dienstmann, Spain

Event moderated by Stefan Zimmerman, Switzerland.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings